BofA Hikes Ascendis Pharma Price Target to $216 Affirms Buy...
Ascendis Pharma A/S (NASDAQ:ASND) is one of the best 52-week high stocks to buy, according to analysts. On June 9, BofA analyst Tazeen Ahmad reiterated a ‘Buy’ rating on the...
Tag: biopharmaceutical company
2 results found
Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 16 stocks Jim Cramer recently discussed. A caller asked if it was a good time to buy the stock. Cramer replied: “You...
